Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class-Reference-Cited by-同舟云学术

Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class

Published:2022-06-01 Issue:6 Volume:8 Page:879
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Samuel Joseph N.¹,Booth Christopher M.²³⁴,Eisenhauer Elizabeth³,Brundage Michael²³,Berry Scott R.³,Gyawali Bishal²³⁴

Affiliation:

1. School of Medicine, Faculty of Health Sciences, Queen’s University, Kingston, Ontario, Canada

2. Division of Cancer Care and Epidemiology, Cancer Research Institute, School of Medicine, Faculty of Health Sciences, Queen’s University, Kingston, Ontario, Canada

3. Department of Oncology, School of Medicine, Faculty of Health Sciences, Queen’s University, Kingston, Ontario, Canada

4. Department of Public Health Sciences, School of Medicine, Faculty of Health Sciences, Queen’s University, Kingston, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2791674/jamaoncology_samuel_2022_oi_220013_1655232066.72255.pdf

Reference63 articles.

1. Is the number of cancer drug approvals a surrogate for regulatory success?;Gyawali;J Cancer Policy,2019

2. Assessment of the clinical benefit of cancer drugs receiving accelerated approval.;Gyawali;JAMA Intern Med,2019

3. Evaluation of the clinical benefit of cancer drugs submitted for reimbursement recommendation decisions in Canada.;Meyers;JAMA Intern Med,2021

4. Association between progression-free survival and patients’ quality of life in cancer clinical trials.;Hwang;Int J Cancer,2019

5. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.;Marandino;Ann Oncol,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines;Molecular Therapy: Oncology;2024-09

2. Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward;eClinicalMedicine;2024-09

3. Association between health-related quality-of-life results, outcomes of efficacy and drug approvals: a meta-research study of randomized phase III trials in oncology;ESMO Open;2024-08

4. Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer;JCO Global Oncology;2024-08